ENvue Medical, Inc. (FEED)
OTCMKTS · Delayed Price · Currency is USD
1.030
-2.320 (-69.25%)
At close: Sep 15, 2026
ENvue Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue | 1.93 | 2.55 | 2.56 | 2.28 | 0.75 | 1.7 |
Revenue Growth | -17.66% | -0.19% | 12.05% | 203.59% | -55.63% | 172.07% |
Cost of Revenue | 2.43 | 2.4 | 1.05 | 0.75 | 0.59 | 0.93 |
Gross Profit | -0.5 | 0.15 | 1.51 | 1.54 | 0.17 | 0.77 |
Selling, General & Admin | 13.37 | 10.13 | 4.18 | 4.43 | 4.9 | 4.66 |
Research & Development | 1.22 | 1.76 | 0.91 | 0.19 | 0.28 | 0.29 |
Operating Expenses | 14.59 | 11.89 | 5.09 | 4.61 | 5.18 | 4.95 |
Operating Income | -15.09 | -11.74 | -3.58 | -3.08 | -5.01 | -4.18 |
Interest Expense | - | - | -0.1 | -0.25 | -0.05 | -0.05 |
Interest & Investment Income | 4.83 | 4.4 | - | - | - | - |
Other Non Operating Income (Expenses) | - | - | - | - | - | -6.89 |
EBT Excluding Unusual Items | -10.26 | -7.34 | -3.69 | -3.32 | -5.07 | -11.12 |
Impairment of Goodwill | -11.15 | -11.15 | - | - | - | - |
Legal Settlements | - | - | - | -0.36 | -0.35 | -1.5 |
Other Unusual Items | - | - | - | - | - | -1.63 |
Pretax Income | -21.42 | -18.49 | -3.69 | -3.68 | -5.41 | -14.25 |
Income Tax Expense | -0.35 | -0.31 | 0.02 | 0.03 | 0.04 | 0.03 |
Net Income | -21.06 | -18.19 | -3.71 | -3.71 | -5.45 | -14.28 |
Preferred Dividends & Other Adjustments | 28.13 | -1.41 | - | - | - | - |
Net Income to Common | -49.19 | -16.78 | -3.71 | -3.71 | -5.45 | -14.28 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 0 | 0 | - | - | - | - |
Shares Outstanding (Diluted) | 0 | 0 | - | - | - | - |
Shares Change | 1812.95% | - | - | - | - | - |
EPS (Basic) | -206.88 | -320.27 | - | - | - | - |
EPS (Diluted) | -206.88 | -320.27 | - | - | - | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -11.74 | -9.43 | -2.52 | -3.6 | -7.04 | -4.37 |
Free Cash Flow Per Share | -49.39 | -180.08 | - | - | - | - |
Gross Margin | -26.06% | 5.99% | 58.95% | 67.32% | 22.21% | 45.43% |
Operating Margin | -783.59% | -459.65% | -140.03% | -134.74% | -666.49% | -246.78% |
Profit Margin | -2553.89% | -657.07% | -144.84% | -162.55% | -724.47% | -842.60% |
Free Cash Flow Margin | -609.76% | -369.45% | -98.47% | -157.82% | -935.90% | -257.82% |
EBITDA | -14.14 | -10.84 | -3.58 | -3.08 | -5.01 | -4.18 |
EBITDA Margin | - | - | -139.99% | -134.69% | - | -246.67% |
D&A For EBITDA | 0.95 | 0.9 | 0 | 0 | 0 | 0 |
EBIT | -15.09 | -11.74 | -3.58 | -3.08 | -5.01 | -4.18 |
EBIT Margin | - | - | -140.03% | -134.74% | - | -246.78% |